Table 2.
Outcomes Among All Stimulated* Cycles versus those Clinically Assigned as DOR
*Cycles with a daily FSH dose = 0 or missing were excluded
| 2004 Cycles | 2011 Cycles | Combined 2004 and 2011 | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| ALL STIMULATED CYCLES: | All (N=84,099) | Age <40y (N=66,779) | All (N=90,102) | Age <40y (N=68,642) | All (N=174,201) | Age <40y (N=135,421) |
| POR; N (%) | 13,088b (16) | 8,299a (12) | 13,508b (15) | 7,549a (11) | 26,596 (15) | 15,848 (12) |
| # Oocytes retrieved; (Mean ± SD) | 12.4 ± 7.8e | 13.2 ± 7.9f | 12.3 ± 7.8 e | 13.3 ± 7.9f | 12.4 ± 7.8 | 13.3 ± 7.9 |
| Live Birth; N (%) | 23,231a (28) | 21,375a (32) | 26,920a (30) | 24,375a (35) | 50,151 (29) | 45,750 (34) |
|
| ||||||
| DOR SUBSETS: | All DOR (N=15,752) | DOR Age<40y (N=7,952) | All DOR (N=23,559) | DOR Age<40y (N=11,457) | All DOR (N=39,311) | Age<40y (N=19,409) |
|
| ||||||
| POR; N (%) | 5,004c (32) | 2,331d (29) | 7,123c (30) | 3,095d (27) | 12,127 (31) | 5,403 (28) |
| # Oocytes retrieved; (Mean ± SD) | 8.3 ± 5.9 | 8.8 ± 6.1 | 8.3 ± 5.9 | 8.8 ± 6.1 | 8.3 ± 5.9 | 8.8 ± 6.1 |
| Live Birth; N (%) | 2,357a (15) | 1,693a (21) | 4,003a (17) | 2,811a (24) | 6,360 (16) | 4,504 (23) |
2004 vs. 2011:
a
p<0.0001;
b
p=0.0009;
c
p=0.0013;
d
p=0.0001;
e
p=0.0318;
f
p=0.0023